Grantee Name: Dr. Alexandros Papachristofilou
Organization: University Hospital Basel
SAKK 01/18: Reduced intensity radio-chemotherapy for stage IIA/B seminoma
Funding Year: 2018
Project period: 4 years
SAKK 01/18: Reduced-intensity radio-chemotherapy for stage IIA/B seminoma
The main objective of this trial is to conduct a single-arm, multicenter, prospective phase II trial testing different combinations of radiotherapy and chemotherapy based on the results of the current RTFCCR grant to reduce long-term toxicity.